Search

everythinglearnresearchcommunity

for

Search:↓

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

BTNL2 helps protect hair follicles from immune attacks.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Dupilumab users have a higher risk of developing alopecia areata.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Tofacitinib may help regrow hair in alopecia areata patients.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Dupilumab can cause psoriasis in some patients.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.